Precision Medicine Software Market Set to Reach $4.92 Billion by 2030, Driven by Advances in Genomics, Oncology, and AI-Powered Analytics.

The precision medicine software market is projected to reach $2.82 billion in 2026 and $4.92 billion by 2030, driven by advancements in genomic technologies, rising precision oncology, and focus on interoperable healthcare systems. Key players such as Philips, Palantir Technologies, and Tempus Labs are leading the industry. Personalized treatment, which involves tailoring medical care based on genetic profiles, lifestyles, and health histories, is a significant growth factor. The market is expected to witness trends such as AI-driven clinical decision support, integration of genomic and clinical data platforms, and a heightened focus on real-time patient data analytics and interoperable healthcare systems.